Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine, a leader in artificial intelligence (AI) for use in drug discovery. Since 2012, he has published over 120 peer-reviewed research papers. Evelyne Bischof, MD, is an internist, associate professor at the Shanghai University of Medicine and Health Sciences, and physician at the University Hospital Basel, a consultant to Insilico.
